Latest News

Centessa Pharmaceuticals recently reported past Phase II progress for its orexin agonist ORX750 in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia, highlighting clinically meaningful effects alongside a favorable safety and tolerability profile. The company also outlined plans for registrational studies in rare hypersomnias, expanded its open-label extension to four weeks, and began preparing for regulatory engagement and commercial build-out, underscoring how central ORX750...

If you are wondering whether MACOM Technology Solutions Holdings at around US$222.55 is still reasonably priced after its strong run, you are not alone. This article will focus on what that price might imply about value. The stock has seen a 6.9% decline over the past week and a 5.6% decline over the past month, yet it still sits on returns of 27.2% year to date and 108.0% over the past year, with a 224.5% return over three years and 233.3% over five years. Recent attention on the...

Netskope, Inc. has reported its fourth-quarter 2026 results, with sales of US$196.33 million and a net loss of US$56.77 million, and unveiled guidance for fiscal 2027 alongside the launch of its Netskope One AI Security suite. The introduction of Netskope One AI Security, which combines agentic AI protection, guardrails, gateways, and red teaming in a unified platform, positions the company directly in the emerging market for securing generative and enterprise AI use. We’ll now examine how...

Atlantic Union Bankshares Corporation recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, drawing fresh attention from institutional investors. This event coincides with elevated call-option implied volatility and more optimistic analyst views, highlighting growing interest in the bank’s earnings outlook and risk profile. We’ll now examine how this heightened options activity and analyst optimism interact with Atlantic Union Bankshares’ existing...

Campbell's (CPB) has just reported its latest results with Q2 2026 revenue of US$2.68 billion and basic EPS of US$0.65, setting the tone for how the rest of the year may shape up. Looking back over recent quarters, revenue has moved between US$2.29 billion in Q4 2024 and US$2.77 billion in Q1 2025, while basic EPS has ranged from a small loss of US$0.01 in Q4 2024 to US$0.73 in Q1 2025. This gives investors a clear view of how sales and earnings have tracked into this quarter. With net income...

Conference spotlight and why AIRO is on more investor radars AIRO Group Holdings (AIRO) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference on March 11 in New York, giving investors a closer look at its aerospace and defense business. With Co Founder and Executive Chairman Chirinjeev Baboo Kathuria, Chief Executive Officer Joe Burns and Chief Financial Officer Mariya Pylypiv on stage, the session could offer more detail on AIRO’s drone, avionics, training and...

Origin Energy in focus after oil price spike The recent surge in oil prices above US$100 per barrel has sharpened attention on Origin Energy (ASX:ORG), given its 27.5% interest in the Australia Pacific LNG project and exposure to higher LNG pricing. See our latest analysis for Origin Energy. Despite the latest share price of A$11.59 and a 1-day share price return decline of 0.34%, Origin’s 30-day share price return of 5.46% and 1-year total shareholder return of 19.41% suggest momentum has...

Are you wondering whether Westlake's current share price reflects its true worth, or if the market is missing something important about this chemicals producer's future potential? Recently, the stock closed at US$107.03, with returns of 0.8% over 7 days, 10.9% over 30 days, 44.3% year to date, and 2.8% over the past year. These figures may have changed how some investors think about its risk and reward profile. Recent coverage of Westlake has focused on its position in basic materials and...

Utz Brands (NYSE:UTZ) presented new protein-enriched snacks and globally inspired flavors at Natural Products Expo West. The lineup includes Boulder Canyon Agave Sriracha kettle chips and a high protein snack range with gluten free, non GMO, and kosher options. The launch targets growing interest in snacks that combine higher protein content with bolder, globally influenced taste profiles. For investors watching NYSE:UTZ, the new products come at a time when the share price is around $7.52,...

Recent share performance and business snapshot Taylor Morrison Home (TMHC) has drawn investor attention after a recent stretch of weaker share performance, including negative returns over the past week, month and past 3 months, despite a small positive move year to date. The US homebuilder and land developer reported annual revenue of US$8.1b and net income of US$782.5m, giving investors a sense of its current earnings base as they weigh the recent pullback in the share price. See our latest...

Carel Industries (BIT:CRL) is back in focus after reporting full year 2025 results, with higher sales, net income, and earnings per share, alongside a broker upgrade following a strong fourth quarter. See our latest analysis for Carel Industries. The stock has picked up momentum recently, with a 1 month share price return of 8.63% and a 7 day gain of 4.38% to €22.65. This comes even though the 3 month share price return is a 9.76% decline and the 3 year total shareholder return is slightly...

Guidance update and why it matters for Erste Group Bank (WBAG:EBS) Erste Group Bank (WBAG:EBS) has issued earnings guidance for 2026, targeting net interest income above €11b. This forward looking target is a key reference point for investors assessing the bank’s revenue mix. See our latest analysis for Erste Group Bank. The shares currently trade at €96.75, with a 30 day share price return of an 11.56% decline and a year to date share price return of a 6.88% decline. This is set against a...

Wondering if Hubbell at around US$477.97 is priced for perfection or still leaves room on the table? This article walks through the numbers so you can judge whether the current tag feels stretched or reasonable. The stock has seen a 2.6% decline over the past week and a 5.6% decline over the last 30 days, while still sitting on a 44.6% 1 year return and a 172.8% return over 5 years. That mix of recent pullback and longer term strength raises fair questions about where value stands...

Harley-Davidson CEO and a company director recently purchased additional NYSE:HOG shares. Director Lori Flees made a sizeable insider purchase, increasing her personal stake in the company. These transactions add a fresh data point on insider sentiment at a time when the share price is around $18.2. For investors watching Harley-Davidson, the insider buying comes after a tough stretch for NYSE:HOG, with the stock down 6.5% over the past week and 9.6% over the past month. Returns are also...

C.H. Robinson Worldwide (NasdaqGS:CHRW) has publicly detailed the scale of its proprietary logistics dataset, which now feeds over 100 trillion real world data points into its Lean AI system. The expanded AI platform coordinates hundreds of AI agents that support millions of shipping decisions across global freight and logistics operations. The company reports measurable benefits for customers, including faster time to market and more consistent pickup performance. C.H. Robinson is putting...

If you are looking at Coupang and wondering whether the current share price reflects its true worth, you are not alone. Many investors are asking the same question. Coupang's share price closed at US$18.77 most recently, with returns of a 1.7% decline over the last 7 days, a 1.2% gain over 30 days, a 19.7% decline year to date and a 15.7% decline over 1 year, while the 3 year return sits at 45.4% and the 5 year return at a 56.6% decline. Recent coverage around Coupang has focused on its...

What the MetsäBoard Pro FBB Go launch could mean for HLSE:METSB investors Metsä Board Oyj (HLSE:METSB) has introduced MetsäBoard Pro FBB Go, a fresh fibre folding boxboard aimed at European food and pharmaceutical packaging, alongside faster custom cut sheet delivery services for regional customers. The new grade is produced at the Husum mill in Sweden and sheeted in the Netherlands, with Metsä Board highlighting short, predictable lead times and services that target deliveries in less than...

Wondering whether Capricor Therapeutics at around US$33.57 is still offering value or has already priced in the story? This article will walk you through what the numbers are actually saying about the stock. The share price has been volatile, with returns of 31.6% over the past week, 33.3% over the past month, 18.6% year to date, and 156.8% over the last year, alongside a very large 3 year gain and a more than 5x gain over 5 years. Recent interest in Capricor Therapeutics has been shaped by...

Australian Strategic Materials (ASX:ASM) has just posted its H1 2026 scorecard, with trailing 12 month revenue of A$10.1 million and a net loss of A$21.6 million, translating to a basic EPS loss of A$0.11. Over recent half year periods the company has seen revenue move from A$1.96 million in H2 2024 to A$2.20 million in H1 2025 and A$2.89 million in H2 2025, while basic EPS losses shifted from A$0.10 to A$0.08 and then A$0.06, setting up a results story where investors are weighing growing...

Denison Mines has approved the final investment decision for its Phoenix in situ recovery uranium mine. The company has started site preparation and construction work at Phoenix following this decision. Denison received a federal construction licence from the Canadian Nuclear Safety Commission, the first of its kind for a Canadian uranium mine in over 20 years. A major construction management contract has been awarded to a leading engineering firm to oversee project delivery. For investors...

Evotec (XTRA:EVT) has drawn fresh attention after beating its full-year 2025 revenue expectations and unveiling its Horizon transformation plan, a new mid term framework aimed at refocusing drug discovery and development efforts. See our latest analysis for Evotec. Despite the Horizon announcement and revenue beat, sentiment has been weak, with a 30 day share price return of 30.19% decline and a 1 year total shareholder return of 29.86% loss, indicating fading momentum. If this shift in...

Why Swire Pacific’s Latest Earnings Are Drawing Investor Attention Swire Pacific (SEHK:19) has released its full year 2025 results, with sales of HK$90,467 million compared to HK$81,969 million a year earlier, while net income was HK$2,938 million versus HK$4,321 million. This mix of higher sales and lower profit is central to how investors may be reassessing the stock today, as it raises questions about cost pressures, business mix and earnings quality across the group’s divisions. See our...

Recent trading in Sila Realty Trust (SILA) has been influenced by Truist Securities maintaining a positive view after the latest quarterly update, where earnings per share missed expectations but revenue came in slightly ahead of forecasts. See our latest analysis for Sila Realty Trust. At a share price of US$25.03, Sila Realty Trust has seen a 1-day share price return of 1.38% and a 90-day share price return of 11.05%. Its 1-year total shareholder return of 5.07% and 3-year total shareholder...

Mosaic (NYSE:MOS) has entered a joint agreement with Rainbow Rare Earths to advance the Uberaba rare earths project in Brazil. The partners plan to process phosphogypsum, a fertilizer byproduct, to produce rare earths such as neodymium and praseodymium. The initiative expands Mosaic’s business focus beyond fertilizers into materials used in clean energy and high tech applications. Mosaic, trading at $29.15, is better known for its fertilizers, so this rare earths move gives investors a...